• Blood Cancers
  • Genitourinary Cancers
  • Brain Cancer
  • Breast Cancer
  • Childhood Cancers
  • Gastric Cancers
  • Gynecologic Cancer
  • Head & Neck Cancer
  • Immunotherapy
  • Leukemia
  • Lung Cancer
  • Lymphoma
  • Myeloma
  • Rare Cancers
  • Sarcoma
  • Skin Cancer
  • Thyroid Cancer

Survey Explores Disparities Black Women With TNBC Face


A triple-negative breast cancer survivor discussed disparities she faced when undergoing cancer care.

Research has shown that Black women with triple-negative breast cancer (TNBC) tend to have higher mortality rates than their White counterparts. According to a survey conducted by the Tigerlily Foundation presented at the 2023 San Antonio Breast Cancer Symposium, more than half (52%) of Black women who participated reported that they did not receive biomarker-driven cancer care.

In an interview with CURE® TNBC survivor, Catrina Crutcher, discusses disparities that she faced during her cancer treatment.

“It's those type of disparities that I don't want Black women or brown women to experience because we all deserve the best treatment, no matter the insurance that we have,” she said.


My experiences with disparities is I wasn't provided all of the necessary options for TNBC. It was straight, “only this medication, and this surgery and this chemotherapy and radiation therapy.” I was not provided the option of a clinical trial, or any type of other therapy besides immunotherapy, and for me, immunotherapy did not work, even though the FDA approved it. It gave me a pancreatitis. I was in the hospital for 10 days, I lost 34 pounds, and it was horrible. And I still have side effects from that experience. So I think, learning from my other peers who have been through breast cancer and who have triple-negative (breast cancer) learning that we don't have the same treatment options.

And also when it comes to insurance, I had shared a conversation with my doctor, (that) unfortunately, I lost my role, and my employer let me go. And I had told my oncologist, “Hey, I no longer have insurance.” And the fact that he immediately told me, “I cannot see you anymore,” was like, “Well, hold on. I have backups. I'm on my fiancé’s insurance.” But just to jump point and just say, “Oh, I can't see you again,” with that disparity without knowing what I have on the back burner or something just to have a backup plan. You didn't know that. For you to jump to that you can't see me and I’ve got to go to a lesser hospital that won't give me the treatment options. I didn't like that conversation. And I did have to correct him. And I did say something at that moment. It's those type of disparities that I don't want Black women or brown women to experience because we all deserve the best treatment, no matter the insurance that we have.

For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.

Related Videos
Woman with dark brown hair and pink lipstick wearing a light pink blouse with a light brown blazer. Patients should have conversations with their providers about treatments after receiving diagnoses.
Man in a navy suit with a purple tie. Dr. Saby George talks to CURE about how treatment with Opdivo could mitigate disparities in patients with kidney cancer.
Dr. Kim in an interview with CURE
Dr. Barzi in an interview with CURE
Sue Friedman in an interview with CURE
Related Content